Alan Fuhrman Tyra Biosciences, Inc. (TYRA) insider trading activity

TYRA Quotes by TradingView

Alan Fuhrman is Chief Financial Officer of Tyra Biosciences, Inc.. Currently has a direct ownership of 2,395 shares of TYRA, which is worth approximately $39,996. The most recent transaction as insider was on Mar 15, 2024, when has been sold 932 shares (Common Stock) at a price of $12.48 per share, resulting in proceeds of $11,631. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.4K
0% 3M change
n/a 12M change
Total Value Held $39,996

Alan Fuhrman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 15 2024
BUY
Grant, award, or other acquisition
$11,631 $12.48 p/Share
932 Added 28.01%
2,395 Common Stock
Sep 15 2023
BUY
Grant, award, or other acquisition
$18,287 $12.5 p/Share
1,463 Added 50.0%
1,463 Common Stock

Also insider at

SWTX
SpringWorks Therapeutics, Inc. Healthcare
Director
ESPR
Esperion Therapeutics, Inc. Healthcare
Director
CMPI
Checkmate Pharmaceuticals, Inc.
Director
AF

Alan Fuhrman

Chief Financial Officer
Stamford, CT

Track Institutional and Insider Activities on TYRA

Follow Tyra Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TYRA shares.

Notify only if

Insider Trading

Get notified when an Tyra Biosciences, Inc. insider buys or sells TYRA shares.

Notify only if

News

Receive news related to Tyra Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TYRA